• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA

    2019-02-12 12:58:34LucieBeneovTerezalkovRenataPtkovAnastasiyaSemyakinaKateinaMenclovJiPudilMiroslavRyskaMiroslavLevJaromimFilipPazdrekJiHochMilanBlahaMarekMinrik
    World Journal of Gastroenterology 2019年48期

    Lucie Bene?ová, Tereza Hálková, Renata Ptá?ková, Anastasiya Semyakina, Kate?ina Menclová, Ji?í Pudil,Miroslav Ryska, Miroslav Levy, Jaromír ?im?a, Filip Pazdírek, Ji?í Hoch, Milan Blaha, Marek Minárik

    Abstract

    Key words: Circulating tumor DNA; Metastatic colorectal cancer; Postoperative;Radicality of resection; Follow-up; Recurrence

    INTRODUCTION

    Around 50% of patients with colorectal cancer (CRC) are found to have synchronous liver or extrahepatic metastases at the time of diagnosis or will develop metachronous metastases within several years after surgery[1]. It is known that radical surgical resection - the R0 resection which involves a complete removal of the diseased tissue -is the only effective treatment option, ideally in combination with perioperative chemotherapy[2]. The 5-year survival rate for patients with surgical treatment ranges from 41% to over 70% compared to 5% if not treated[3-5].

    Besides removal of metastases, postoperative patient follow-up is no less important as it allows for the timely identification of any progression or recurrence of the disease and prompt therapeutical response - whether by surgery or modification of systematic therapy. The monitoring of patients with metastatic CRC is predominantly based on imaging techniques such as ultrasonography (US), computed tomography(CT), positron emission tomography (PET), magnetic resonance imaging (MRI) or X-ray imaging (XRAY), usually with assessments of serum tumor markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9). Nowadays,molecular biology techniques also play an irreplaceable role in the management of patients with CRC, considering that the decisions on cancer therapy are ever more supported by the knowledge of biological characteristics and genetic profile of the disease[6]. Most recently, the possibility for disease follow-up using circulating tumor DNA (ctDNA) has become available in addition to already implemented mutation profiling from tissue biopsies or resecates[7,8].

    The term ctDNA means short fragmented DNA, which has historically been observed in blood circulation of patients suffering with metastatic stages of cancers[9,10]. ctDNA is often referred to as cell-free DNA to emphasize its exogenous nature in comparison to DNA originating from nuclei of the blood cells. Although the exact mechanism of its release into circulation is still subject to debate, there are several probable mechanisms of the ctDNA origin including: Apoptosis; necrosis;active release through lipoproteonucleotidic complexes (virtosomes); phagocytosis;and exocytosis[11]. Due to its exclusive origin in cancerous cells, ctDNA retains the fundamental imprint of its cancer genome including cancer-specific aberrations such as somatic mutations. Therefore, the ctDNA analysis has recently been promoted using the term “l(fā)iquid biopsy”[12]. The main advantage of liquid biopsy, compared to the “classic” biopsy of tumor tissues is its minimal invasiveness and the associated minimal stress for the patient. Additionally, ctDNA is released to the bloodstream from all tumor foci, and thus a single blood sample contains the complete mutation spectrum of cancer clones present in the patient's body[13].

    Besides liquid biopsy, ctDNA testing has proven to be a very promising instrument for long-term, postoperative follow-ups of patients with CRC, particularly in advanced stages. Being minimally invasive, it can be repeated over short periods for a long time with no significant burden to the patient, and moreover, this test shows high sensitivity and specificity to patients with preoperative ctDNA positivity[14]. The approach fundamentally relies on the applied methodology, which must be able to capture < 0.1% of ctDNA on the background of non-tumor DNA. Accordingly, the current techniques include dedicated approaches such as those based on digital PCR,BEAMing or deep sequencing[15]. In all cases, tumor-specific DNA alterations (usually mutations) found in the tumor tissue or occurring with a certain significant frequency in the given cancer are used as ctDNA positivity markers. However, the above mentioned methods have their limitations, particularly in terms of higher demands on the input DNA amount and the costs. Another sensitive, efficient, rapid and affordable method based on the formation of heteroduplexes with subsequent detection using denaturing capillary electrophoresis (DCE) has been used at our center for 10 years. This method can be used to detect a mutated locus in plasma with the sensitivity of 0.03% to 1% depending on the mutation to be determined (Table 1)with input DNA amount of tens of pg[16,17]. The specificity of this ctDNA test is 100%,which means that the presence of ctDNA always provides evidence that a tumor residue or tumor cells are present. As previously shown by us, ctDNA testing using DCE allows patient follow-up in real time, while ctDNA levels correlate very well with the current condition of the patient[17]. As we reported in this paper about a group of patients with metastatic CRC, ctDNA can be used in clinical practice,particularly for the evaluation of the radicality of surgery and for the timely detection of any progression or recurrence of the disease.

    MATERIALS AND METHODS

    Patients and samples

    This study was conducted in cooperation with three prime surgery centers in the Czech Republic in accordance with the Declaration of Helsinki and was approved by ethics committees of the relevant hospitals. The forty-seven patients enrolled in the study had undergone the resection of synchronous or metachronous colorectal cancer metastases and tested positive for ctDNA before surgery, and were thus suitable candidates for postoperative ctDNA follow-up. Patient characteristics are listed in Table 2. All patients signed an informed consent form for the study. A tumor tissue sample was surgically obtained in each case. Peripheral blood samples for ctDNA analysis were collected in an anticoagulant solution before, 1 week after the surgery,and subsequently in several-month intervals during their follow-ups. Clinical patient data including tumor localization and type, surgical radicality, and CEA and CA 19-9 marker levels were also collected.

    Table 1 Characteristics of the markers used for the mutation analysis[16,17]

    DNA isolation and detection of mutations

    Mutation profiles were determined in DNA isolated from tumor tissues,subsequently, the detected mutations were analyzed in plasma samples. Tumor DNA was isolated from the samples of native frozen (-20 °C) tissues using the GenElute?Mammalian Genomic DNA Miniprep Kit (Sigma Aldrich, St. Louis, MS, United States). ctDNA was isolated using the NucleoSpin Plasma XS (Macherey-Nagel,Dueren, Germany) from plasma according to the instructions of the manufacturer.Plasma was obtained by centrifugation of blood promptly after collection, and then immediately frozen at -20 °C. The mutations were identified using a panel for the detection of the most commonly mutated loci in theKRAS,TP53,APC,PIK3CA,BRAFandCTNNB1genes, which are characteristic for colorectal cancer (see Table 1 for details). Tumor tissue and ctDNA mutations were detected using PCR with the formation of heteroduplexes and subsequent separation using DCE. The principle of the method has been described previously[18].

    Resection radicality and recurrence of the disease

    The radicality of surgical removal of colorectal cancer metastases was determined by the pathologist based on examination of the resected samples' margins. Complete resections with no macroscopic or microscopic tumor residues were identified as R0.For R0 resections, the minimum distance of tumor cells from the resection line was > 0 mm. Microscopically incomplete resections, with a presence of tumor cells in the margin detected by the pathologist, were identified as R1. Macroscopically incomplete resections were identified as R2 and were classified as R2a (macroscopic presence of a residue of the primary tumor), R2b (macroscopic presence of distal metastases), R2c(macroscopic presence of any residue(s) of the primary tumor as well as of distal metastases)[19]. The surgical radicality assessments were supplemented with an analysis of postoperative ctDNA.

    Disease recurrence was longitudinally monitored and was assessed using imaging methods (most commonly CT, MRI, US, XRAY) and using CEA (normal levels ≤ 5 ng/mL) and CA19-9 (normal levels ≤ 37 U/mL) tumor marker levels. Any abnormalities detected by imaging techniques or elevated levels of at least one tumor marker were considered recurrences. This data were correlated with the presence of ctDNA. The ctDNA was evaluated until recurrence or during the patient's follow-up period.

    Table 2 Clinical patient data

    RESULTS

    Detailed information on the 47 patients enrolled in the study is available in Supplementary Table 1. In total, 79 tumor tissue samples (25 from the primary tumor, 6 from lymph nodes and 48 from distal metastases) and 202 plasma samples (51 before surgery, 39 after surgery and 112 during follow-up) were collected over the course of the study. A detailed overview of the collected samples and mutations detected in tumor tissue is provided in Supplementary Table 2.

    Sixty-three resections were done during the study (including repeated resections during follow-up), which comprised 40 R0, 7 R1 and 16 R2 resections. A postoperative ctDNA sample to assess the correlation of ctDNA and surgery radicality was available for 39 patients undergoing 50 surgeries (28 R0, 7 R1 and 15 R2) (Table 3; for detailed information see Supplementary Table 1). Among the 28 cases of R0 resection,postoperative ctDNA tested negative in 26 cases (26/28, 93%). After the first of the two remaining R0 surgeries, a RFA of a small metastasis in the liver, the patient continued displaying ctDNA and, subsequently, was diagnosed with disease recurrence within the scar 6 mo after the surgery. The second case of ctDNA positivity after R0 surgery was a right-sided hemicolectomy with metastasectomy. Also, in this case, the recurrence (two new liver metastases) was visibleviaimaging methods 6 months after the surgery.

    In 7 cases with R1 resection, postoperative ctDNA was positive 4 times (4/7, 57%)with disease recurrence 3, 3, 4 and 7 mo after surgery in these cases. For the remaining 3 patients with negative ctDNA after R1 surgery (3/7, 43%), two of them had postoperative recurrence after 7 or 22 mo, and the third one has gone 5 months with no recurrence after surgery. Postoperative ctDNA was positive in all 15 patients with R2 resection (15/15, 100%).

    Postoperative tumor recurrence was evaluated according to positive results of ctDNA testing, imaging methods and tumor marker assessments. In our set of 32patients undergoing R0 resections of liver metastases and long-term postoperative monitoring, 22 patients had recurrences (22/32, 69%, see Supplementary Table 1). In 17 patients, from whom all parameters for the detection of postoperative tumor recurrence were available, a total of 22 recurrences were confirmed (3 patients had repeated recurrences - 2 and 4 recurrences). Thirteen times (13/22, 59%) the recurrence was simultaneously detected by ctDNA, imaging methods and tumor markers. Seven times (7/22, 32%) the tumor markers were negative and 6 times (6/22,27%) the imaging methods were without evidence of tumor. The ctDNA was not negative even once (0/22, 0%), making ctDNA in our study the most sensitive tool for detecting tumor recurrence of all three methods. In four patients (4/22, 18%) the tumor recurrence was detected by ctDNA only, while imaging methods and tumor markers were negative (Table 4).

    Table 3 Correlation of surgical radicality and postoperative circulating tumor DNA

    DISCUSSION

    Radicality of surgery is normally assessed based on histological examination of a resected sample and based on the results of imaging methods. However, these examinations cannot indicate any potential presence of circulating tumor cells found in the bloodstream or lymphatic pathways due to a metastatic process or dissemination during surgery. Potential presence of microscopic metastases cannot be demonstrated using histology or imaging methods either. Although the follow-up of tumor marker levels may be useful for detection, their sensitivity and specificity are low[20]. ctDNA is a highly dynamic marker with an approximate half-life of 2 hours,and its levels correspond to the clinical condition of patients with mCRC[17,21]. As we have shown in this paper, a postoperative presence of ctDNA correlates very well with surgery radicality, and its elevated levels in R0 and R1 resections may signal the occurrence of micrometastases and thus help to identify patients with an increased risk of early recurrence for a higher frequency of their follow-up assessments or for an indication of adjuvant therapy[22-24].

    To date, only three papers have been published studying the presence of ctDNA immediately after CRC resection. One study in 2005 focused onKRASmutation persistence in the plasma of patients with colorectal cancer in various stages 3 days from radical surgery. As surprisingly indicated by the results, most patients with preoperatively detectedKRASmutations in plasma had the same mutations detected in plasma, also 3 days from radical surgery (7/9, 78%). Only two patients had no mutation detected in the postoperative period (2/9, 22%)[25]. As mentioned in another study, ctDNA can provide information on radicality of primary resection of colorectal cancer, which was illustrated in the case of a patient where evidence of insufficient radicality of the primary surgery was provided based on the presence of postoperative ctDNA[26]. The last study from 2016 showed a correlation between R0 resections and postoperative ctDNA negativity in 75% of patients (6/8) and a correlation between R2 resection and postoperative ctDNA positivity in 67% of patients (2/3), by presenting a set of 11 patients with preoperatively positive ctDNA results, undergoing R0 (8 times) or R2 (3 times) resection[27].

    Compared to the above mentioned studies, our study presents the largest group of patients so far with preoperatively detected ctDNA (47 in total) in whom postoperative ctDNA correlation with surgery radicality was followed, and this studyis also the first to report ctDNA correlation with R1 resection. In our group of patients who underwent R1 resections, more than half of them were postoperative ctDNA positive. Considering that in these patients, only a small number of tumor cells were present in the resection margin that they are unlikely to release their DNA into the bloodstream, ctDNA positivity could indicate that there are still other micrometastases not detected by imaging methods. This corresponds to significantly shorter times without recurrence (3, 3, 4 and 7 mo) compared to patients with negative postoperative ctDNA (7 and 22 mo). The presence of micrometastases was also probably recognized in two postoperative ctDNA-positive patients undergoing R0 resection, as their time to recurrence was also very short (6 mo both) when compared to patients with negative R0 postoperative ctDNA (14 times recurrence after 4-22 mo, 10 times no recurrence in surveillance 6-36 mo). Unlike other studies,postoperative ctDNA positivity was captured in all R2 resections (15/15, 100%) in our study, which may be due to the sensitivity of the used detection methods. Our DCE method provides the limit of detection (LOD) of 0.03%-1% (see Table 1), while the studies referred to above used the Temperature Gradient Gel Electrophoresis method with LOD 1%-5%[28]and the Quantitative Polymerase Chain Reaction assay based on allele-specific PCR with LOD 1%-2%[29].

    Table 4 Comparison of circulating tumor DNA and standard detection methods

    Liver metastatic recurrence occurs in approximately 50% of patients undergoing hepatectomy, while 12% have a recurrence more than once. Considering that repeated hepatectomy combined with systemic therapy may improve overall survival of these patients[30-32], efficient follow-ups for the early detection of recurrence is very important[33].

    Tumor markers are commonly used for follow-ups, but so far cannot be used alone to diagnose recurrence, and imaging methods sometimes do not recognize small foci(micrometastases) or, on the contrary, find abnormalities that are not cancer.Examination of ctDNA could be another tool used during follow-up. Our detection method enables high reliability testing (the false positive probability of ctDNA is 0%).In our 22 cases of postoperative tumor recurrence imaging methods and tumor marker results detected a recurrence in 16/22 (73%) and 15/22 (68%) cases,respectively, ctDNA was present in 22/22 (100%) cases. Our results are consistent with the findings of several similar studies that have been performed on a comparable or smaller number of samples[24,26,34-36]. Therefore, we consider our set of 22 recurrences after curative (R0) surgical treatment recorded in our study as adequate to confirm utility of the ctDNA test as a viable tool for the early detection of mCRC recurrence.

    Compared to our overall ctDNA detection rate in patients with advanced CRC at the time of the diagnosis (55%-75%), the detection rate in patients previously tested positive for ctDNA is much higher. This data indicates that although the ctDNA release rate into the bloodstream due to the presence of tumor foci differs in various patients with mCRC, for each given patient this phenomenon is relatively stable; thus if ctDNA is detectable in the body when tumor foci are present, it is highly probable that after their complete removal and subsequent recurrence, ctDNA will be detected again.

    Although ctDNA detection cannot replace traditional methods used in the followup scheme, it might be a useful supplementary instrument for both the prediction and earlier detection of recurrences, particularly in patients with a higher risk of liver metastatic recurrence[37], and thus it may actually improve the overall survival odds of such patients.

    ARTICLE HIGHLIGHTS

    extrahepatic metastases at the time of diagnosis, or will develop metachronous metastases within several years after surgery. It is known that radical surgical resection, the R0 resection which involves a complete removal of the diseased tissue, is the only effective treatment option, ideally in combination with perioperative chemotherapy. Besides removal of colorectal cancer metastases, postoperative patient follow-up is no less important as it allows for the timely identification of any progression or recurrence of the disease and prompt therapeutical response.The monitoring of patients is predominantly based on imaging techniques, usually with assessments of serum tumor markers. One of the promising tools for long-term postoperative follow-up is the detection of circulating tumor DNA (ctDNA) in the peripheral blood. Sometimes referred to as a "liquid (re)biopsy" it is a minimally invasive procedure and can be performed repeatedly at relatively short intervals (months or even weeks). The presence of the disease and the actual extent of the tumor burden (tumor mass) within the patient's body can be monitored.This is of particular importance, especially when evaluating radicality of surgical treatment as well as for early detection of disease progression or recurrence.

    Research motivation

    Radicality of surgery is normally assessed using histological examination of a resected sample and based on the results of imaging methods. However, these examinations cannot indicate any potential presence of circulating tumor cells or microscopic metastases. Also, the main tools used for postoperative patient follow-up, imaging methods and tumor markers, are often not sufficient in early detection of disease progression or recurrence. Tumor markers have low specificity and sensitivity so that they cannot be used alone to diagnose recurrence. Imaging methods are known to fail to detect small foci (micrometastases) or, on the contrary, find abnormalities that are not cancer. Moreover, they cannot be performed frequently due to the radiation exposure. The recently introduced ctDNA testing could present a useful alternative tool. It has proven to be very promising for long-term, postoperative follow-ups of patients with CRC, particularly in advanced stages. Being minimally invasive, it can be repeated frequently for a long time with no significant burden to the patient, and moreover, this test shows high sensitivity and specificity to patients with preoperative ctDNA positivity.

    Research objectives

    The main objectives of the study were to confirm the radicality of surgery using ctDNA and to compare available methods for detection of recurrence in metastatic CRC (mCRC). It is important to verify whether ctDNA can be used in clinical practice, particularly for the evaluation of the radicality of surgery and for the timely detection of any progression or recurrence of the disease.

    Research methods

    A total of 47 patients with detected ctDNA and indications for resection of mCRC were enrolled in the multicenter study involving three surgical centers. Standard postoperative follow-ups using imaging techniques and the determination of tumor markers were supplemented by ctDNA sampling. In addition to the baseline ctDNA testing prior to surgery, a postoperative observation was conducted by evaluating ctDNA presence up to a week after surgery and subsequently at approximately three-month intervals. The presence of ctDNA was correlated with radicality of surgical treatment and the actual clinical status of the patient. To test ctDNA,we performed a sensitive, efficient, rapid and affordable method based on the formation of heteroduplexes with subsequent detection using denaturing capillary electrophoresis (DCE).This method can be used to detect a mutated locus in plasma with the sensitivity of 0.03% to 1%depending on the mutation to be determined with input DNA amount of tens of pg. The specificity of this ctDNA test is 100%, which means that the presence of ctDNA always provides evidence that a tumor residue or tumor cells are present. As previously shown by us, ctDNA testing using DCE allows a patient follow-up in real time, while ctDNA levels correlate very well with the current condition of the patient.

    Research results

    Among the monitored patients, the R0 (curative) resection correlated with postoperative ctDNA negativity in 26 out of 28 cases of surgical procedures (93%). In the remaining cases of R0 surgeries that displayed ctDNA, both patients were diagnosed with a recurrence of the disease after 6 mo. In 7 patients who underwent an R1 resection, 4 ctDNA positivities (57%) were detected after surgery and associated with the confirmation of early disease recurrence (after 3-7 mo). All 15 patients undergoing R2 resection remained constantly ctDNA positive during the entire follow-up period. In 22 cases of recurrence, ctDNA positivity was detected 22 times (100%)compared to 16 positives (73%) by imaging methods and 15 cases (68%) of elevated tumor markers.

    Research conclusions

    Although ctDNA detection cannot replace traditional methods used in the follow-up scheme, it might represent a useful supplementary instrument for both the prediction and earlier detection of recurrences, particularly in patients with a higher risk of liver metastatic recurrence, and thus it may actually improve the overall survival odds of such patients. And it has also been shown that the ctDNA test is a highly specific and sensitive tool for confirming the radicality of surgical treatment and for the potential prediction of early disease recurrence after R0/R1 surgeries.

    Research perspectives

    In this study, the high sensitivity of the methodology used to test ctDNA after curative mCRC surgical treatment and also to detect recurrence of the disease was shown. However, to confirm this hypothesis, testing on a larger sample set is required. In particular, it is desirable to obtain a greater number of ctDNA positive and negative results after R1 resections that could be correlated with time to disease recurrence. Similarly, expanding the set of long-term follow-up patients using standard approaches supplemented with ctDNA sampling is warranted.

    丰满乱子伦码专区| 欧美日韩福利视频一区二区| 九草在线视频观看| 欧美日韩亚洲高清精品| 黑人欧美特级aaaaaa片| 丝袜人妻中文字幕| 精品人妻熟女毛片av久久网站| 美女视频免费永久观看网站| 一区二区三区四区激情视频| 亚洲天堂av无毛| 亚洲中文av在线| 午夜免费男女啪啪视频观看| 97人妻天天添夜夜摸| 精品一区二区三区av网在线观看 | 黄网站色视频无遮挡免费观看| 啦啦啦中文免费视频观看日本| 亚洲美女视频黄频| 丝袜美腿诱惑在线| 亚洲国产看品久久| 天堂俺去俺来也www色官网| 亚洲精品av麻豆狂野| 日韩中文字幕视频在线看片| 1024视频免费在线观看| 国产成人一区二区在线| 亚洲av在线观看美女高潮| 国产老妇伦熟女老妇高清| 亚洲精品国产色婷婷电影| 国产欧美日韩综合在线一区二区| 色网站视频免费| 久久婷婷青草| 飞空精品影院首页| 国产在视频线精品| 夫妻午夜视频| 久久久久精品久久久久真实原创| 免费观看人在逋| 免费看不卡的av| www.自偷自拍.com| 国产老妇伦熟女老妇高清| 91老司机精品| 成人国语在线视频| 电影成人av| 看十八女毛片水多多多| 日韩欧美一区视频在线观看| 女人被躁到高潮嗷嗷叫费观| 夜夜骑夜夜射夜夜干| 成人漫画全彩无遮挡| 99热国产这里只有精品6| 亚洲欧美一区二区三区黑人| 亚洲第一青青草原| 新久久久久国产一级毛片| 国产乱来视频区| 在线观看www视频免费| 亚洲少妇的诱惑av| 男女床上黄色一级片免费看| 人人妻人人澡人人爽人人夜夜| 国产精品久久久人人做人人爽| 九九爱精品视频在线观看| 欧美日韩av久久| 在线观看免费高清a一片| 一边亲一边摸免费视频| 日韩伦理黄色片| 午夜福利网站1000一区二区三区| 91精品三级在线观看| 美女中出高潮动态图| 飞空精品影院首页| 下体分泌物呈黄色| 啦啦啦在线免费观看视频4| 亚洲av福利一区| 操出白浆在线播放| 欧美精品人与动牲交sv欧美| 成人免费观看视频高清| 免费看不卡的av| 波多野结衣av一区二区av| 亚洲av综合色区一区| www日本在线高清视频| 中文字幕av电影在线播放| 国产精品 欧美亚洲| 亚洲欧洲国产日韩| 日韩人妻精品一区2区三区| 90打野战视频偷拍视频| 亚洲精华国产精华液的使用体验| 新久久久久国产一级毛片| 热re99久久精品国产66热6| 在现免费观看毛片| 91精品国产国语对白视频| 欧美精品av麻豆av| 777米奇影视久久| 在线观看免费午夜福利视频| 伊人亚洲综合成人网| 国产高清不卡午夜福利| 亚洲在久久综合| 男人添女人高潮全过程视频| 亚洲av成人不卡在线观看播放网 | 90打野战视频偷拍视频| a级片在线免费高清观看视频| 日本91视频免费播放| 国产一级毛片在线| 免费高清在线观看日韩| 热99久久久久精品小说推荐| 国产乱人偷精品视频| 久久精品久久久久久久性| 国产片特级美女逼逼视频| 精品卡一卡二卡四卡免费| 校园人妻丝袜中文字幕| 亚洲精品国产色婷婷电影| 成人三级做爰电影| 一本色道久久久久久精品综合| 婷婷色综合大香蕉| 十八禁人妻一区二区| 久久精品国产亚洲av高清一级| 国产成人精品福利久久| 午夜免费男女啪啪视频观看| 欧美97在线视频| 91成人精品电影| 三上悠亚av全集在线观看| 777久久人妻少妇嫩草av网站| 一本久久精品| 99久久99久久久精品蜜桃| 亚洲色图综合在线观看| 精品一区二区三区av网在线观看 | 国产免费现黄频在线看| 在线精品无人区一区二区三| kizo精华| 日韩欧美一区视频在线观看| 日韩视频在线欧美| 国产亚洲精品第一综合不卡| 熟妇人妻不卡中文字幕| 国产无遮挡羞羞视频在线观看| 国产黄色视频一区二区在线观看| 色婷婷久久久亚洲欧美| 人妻人人澡人人爽人人| 一二三四中文在线观看免费高清| 日本av手机在线免费观看| 青春草亚洲视频在线观看| 国产精品三级大全| www.精华液| 精品一区二区三区av网在线观看 | 欧美黑人精品巨大| 国产爽快片一区二区三区| 亚洲精品国产区一区二| 一区二区三区激情视频| 97精品久久久久久久久久精品| av女优亚洲男人天堂| 在现免费观看毛片| 女性被躁到高潮视频| 欧美 亚洲 国产 日韩一| 亚洲自偷自拍图片 自拍| 我要看黄色一级片免费的| 一二三四在线观看免费中文在| 中文字幕精品免费在线观看视频| 亚洲 欧美一区二区三区| 欧美久久黑人一区二区| 激情五月婷婷亚洲| www.熟女人妻精品国产| 丰满乱子伦码专区| 多毛熟女@视频| 午夜久久久在线观看| 免费久久久久久久精品成人欧美视频| 成年女人毛片免费观看观看9 | 亚洲欧美清纯卡通| 午夜福利影视在线免费观看| 王馨瑶露胸无遮挡在线观看| 王馨瑶露胸无遮挡在线观看| 亚洲婷婷狠狠爱综合网| 啦啦啦视频在线资源免费观看| av在线播放精品| 亚洲,一卡二卡三卡| 亚洲 欧美一区二区三区| 国精品久久久久久国模美| 亚洲精品av麻豆狂野| 久久国产亚洲av麻豆专区| 少妇猛男粗大的猛烈进出视频| 啦啦啦在线免费观看视频4| 高清不卡的av网站| 久久韩国三级中文字幕| 亚洲成人手机| 欧美乱码精品一区二区三区| 丰满少妇做爰视频| 亚洲精品国产av成人精品| 中文字幕精品免费在线观看视频| 2021少妇久久久久久久久久久| www日本在线高清视频| 伊人久久大香线蕉亚洲五| www.自偷自拍.com| 日韩欧美一区视频在线观看| 欧美精品高潮呻吟av久久| 国产日韩欧美亚洲二区| 99久久综合免费| 国产成人av激情在线播放| 91老司机精品| 欧美日韩视频高清一区二区三区二| 亚洲欧洲日产国产| 日韩大码丰满熟妇| 制服诱惑二区| 又大又黄又爽视频免费| 亚洲国产av影院在线观看| 国产欧美日韩综合在线一区二区| 中文欧美无线码| 制服诱惑二区| 少妇人妻 视频| 大码成人一级视频| 国产精品亚洲av一区麻豆 | 在线亚洲精品国产二区图片欧美| 国产欧美日韩一区二区三区在线| 婷婷色av中文字幕| 亚洲av综合色区一区| 侵犯人妻中文字幕一二三四区| 最近的中文字幕免费完整| 侵犯人妻中文字幕一二三四区| 黄网站色视频无遮挡免费观看| 韩国av在线不卡| 亚洲熟女毛片儿| 九色亚洲精品在线播放| 国产精品99久久99久久久不卡 | 老司机影院毛片| 久久久久久久久久久免费av| 久久久久精品人妻al黑| 久久久久久久久久久免费av| 免费观看人在逋| 日韩一本色道免费dvd| 久久久亚洲精品成人影院| 一级,二级,三级黄色视频| 欧美精品一区二区免费开放| 日韩不卡一区二区三区视频在线| 国产精品人妻久久久影院| 国产激情久久老熟女| 多毛熟女@视频| 搡老乐熟女国产| 大片免费播放器 马上看| 不卡av一区二区三区| 最近的中文字幕免费完整| 亚洲熟女毛片儿| 啦啦啦啦在线视频资源| 黑人巨大精品欧美一区二区蜜桃| 国产又爽黄色视频| a级片在线免费高清观看视频| 亚洲在久久综合| 九草在线视频观看| 电影成人av| 国产极品粉嫩免费观看在线| 国产成人欧美在线观看 | 97在线人人人人妻| 巨乳人妻的诱惑在线观看| 美女中出高潮动态图| 午夜福利一区二区在线看| 精品少妇黑人巨大在线播放| 精品酒店卫生间| 丝袜美腿诱惑在线| 18在线观看网站| 美女主播在线视频| 日本wwww免费看| 中文字幕最新亚洲高清| 亚洲,一卡二卡三卡| 久久久久网色| 国产乱来视频区| 纯流量卡能插随身wifi吗| 国产又爽黄色视频| 99re6热这里在线精品视频| 精品国产露脸久久av麻豆| 你懂的网址亚洲精品在线观看| 人成视频在线观看免费观看| 观看av在线不卡| 欧美另类一区| 91精品伊人久久大香线蕉| 热re99久久国产66热| 最近手机中文字幕大全| 日韩中文字幕欧美一区二区 | 最近手机中文字幕大全| 一级a爱视频在线免费观看| 日韩制服丝袜自拍偷拍| 国产精品久久久av美女十八| 国产午夜精品一二区理论片| 波野结衣二区三区在线| 又大又爽又粗| 十分钟在线观看高清视频www| 国产成人啪精品午夜网站| 国产成人av激情在线播放| 王馨瑶露胸无遮挡在线观看| 老司机影院成人| 亚洲国产欧美日韩在线播放| av在线app专区| 亚洲av在线观看美女高潮| 欧美日韩亚洲高清精品| 妹子高潮喷水视频| 精品国产超薄肉色丝袜足j| 无遮挡黄片免费观看| 久久天堂一区二区三区四区| 国产免费现黄频在线看| 在线天堂最新版资源| 如日韩欧美国产精品一区二区三区| 人人妻人人澡人人看| 国产亚洲欧美精品永久| 日日爽夜夜爽网站| 久热爱精品视频在线9| 精品亚洲乱码少妇综合久久| 欧美激情 高清一区二区三区| 欧美xxⅹ黑人| 亚洲av男天堂| 国产视频首页在线观看| 99九九在线精品视频| 天堂俺去俺来也www色官网| 巨乳人妻的诱惑在线观看| 男女床上黄色一级片免费看| 一级毛片黄色毛片免费观看视频| 一区在线观看完整版| 男女边吃奶边做爰视频| 午夜91福利影院| 一边摸一边做爽爽视频免费| 韩国精品一区二区三区| 另类亚洲欧美激情| 亚洲中文av在线| 久久精品亚洲av国产电影网| 爱豆传媒免费全集在线观看| 久久久久久久久免费视频了| 免费在线观看视频国产中文字幕亚洲 | 免费在线观看视频国产中文字幕亚洲 | www.自偷自拍.com| h视频一区二区三区| www.av在线官网国产| 麻豆av在线久日| 成人国语在线视频| 亚洲成人手机| 国产亚洲av高清不卡| 91成人精品电影| 国产成人精品在线电影| 日本午夜av视频| 男女高潮啪啪啪动态图| 亚洲国产最新在线播放| 狠狠精品人妻久久久久久综合| 1024香蕉在线观看| 美女大奶头黄色视频| 国产精品秋霞免费鲁丝片| 中文字幕最新亚洲高清| 少妇人妻精品综合一区二区| 精品国产一区二区三区四区第35| 久久久久精品人妻al黑| 人成视频在线观看免费观看| 中文字幕色久视频| 亚洲成人手机| 天天躁夜夜躁狠狠躁躁| 精品人妻熟女毛片av久久网站| 只有这里有精品99| 亚洲综合色网址| 中文字幕高清在线视频| 999久久久国产精品视频| 人妻一区二区av| 日韩人妻精品一区2区三区| 99热网站在线观看| 国产99久久九九免费精品| 亚洲国产欧美日韩在线播放| 人人妻人人爽人人添夜夜欢视频| 亚洲精品自拍成人| 成人三级做爰电影| 一边摸一边抽搐一进一出视频| 国产乱人偷精品视频| 色网站视频免费| 日韩大片免费观看网站| a 毛片基地| 80岁老熟妇乱子伦牲交| 男女免费视频国产| 精品国产乱码久久久久久小说| 极品人妻少妇av视频| 男男h啪啪无遮挡| 亚洲国产成人一精品久久久| 国产精品国产av在线观看| 一级,二级,三级黄色视频| 2018国产大陆天天弄谢| 97人妻天天添夜夜摸| 国产一区有黄有色的免费视频| 女性生殖器流出的白浆| 视频区图区小说| 亚洲成人手机| 熟妇人妻不卡中文字幕| 中文字幕人妻丝袜一区二区 | 亚洲综合精品二区| 波多野结衣av一区二区av| 中文字幕另类日韩欧美亚洲嫩草| 七月丁香在线播放| 夜夜骑夜夜射夜夜干| 熟妇人妻不卡中文字幕| 成人免费观看视频高清| 国产精品秋霞免费鲁丝片| 日日摸夜夜添夜夜爱| 欧美成人午夜精品| 一本一本久久a久久精品综合妖精| 国产黄频视频在线观看| 成人影院久久| 最近2019中文字幕mv第一页| 国产不卡av网站在线观看| 亚洲人成电影观看| 中文字幕最新亚洲高清| 狂野欧美激情性bbbbbb| 亚洲,欧美精品.| 制服诱惑二区| 天堂8中文在线网| 精品国产超薄肉色丝袜足j| 久久鲁丝午夜福利片| 别揉我奶头~嗯~啊~动态视频 | 天天躁狠狠躁夜夜躁狠狠躁| 满18在线观看网站| 国产男女内射视频| 亚洲欧美清纯卡通| 青春草视频在线免费观看| 天天躁夜夜躁狠狠久久av| 久久国产亚洲av麻豆专区| 999精品在线视频| 夫妻性生交免费视频一级片| 桃花免费在线播放| 女人爽到高潮嗷嗷叫在线视频| 亚洲欧美色中文字幕在线| 伊人亚洲综合成人网| 国产精品欧美亚洲77777| 成年人午夜在线观看视频| 亚洲视频免费观看视频| 如日韩欧美国产精品一区二区三区| 久久人人爽av亚洲精品天堂| 麻豆乱淫一区二区| 黄色视频不卡| 色婷婷av一区二区三区视频| 王馨瑶露胸无遮挡在线观看| 高清在线视频一区二区三区| 男的添女的下面高潮视频| 精品一区在线观看国产| 97精品久久久久久久久久精品| 亚洲久久久国产精品| bbb黄色大片| 丰满少妇做爰视频| 在线观看人妻少妇| 视频在线观看一区二区三区| 国产精品 欧美亚洲| 欧美成人午夜精品| 久久av网站| 国产97色在线日韩免费| 成年人午夜在线观看视频| 国产精品香港三级国产av潘金莲 | 午夜福利在线免费观看网站| 在线观看三级黄色| 国产亚洲av高清不卡| 18禁国产床啪视频网站| 99精品久久久久人妻精品| 夜夜骑夜夜射夜夜干| 国产精品香港三级国产av潘金莲 | 亚洲人成77777在线视频| 七月丁香在线播放| 一边摸一边做爽爽视频免费| 亚洲成av片中文字幕在线观看| 波多野结衣一区麻豆| 我要看黄色一级片免费的| 成人午夜精彩视频在线观看| 99精品久久久久人妻精品| 精品少妇内射三级| 国产精品麻豆人妻色哟哟久久| 欧美日韩成人在线一区二区| 国产99久久九九免费精品| 成人亚洲精品一区在线观看| 久久精品久久久久久噜噜老黄| 又黄又粗又硬又大视频| 男女无遮挡免费网站观看| 国产极品天堂在线| 王馨瑶露胸无遮挡在线观看| 欧美97在线视频| 亚洲av中文av极速乱| 午夜福利视频精品| 日韩视频在线欧美| 欧美亚洲 丝袜 人妻 在线| 看免费av毛片| 国产淫语在线视频| 日本av免费视频播放| netflix在线观看网站| 久久婷婷青草| 欧美日韩福利视频一区二区| 欧美日韩国产mv在线观看视频| 亚洲视频免费观看视频| 午夜老司机福利片| 老司机影院成人| 国产伦理片在线播放av一区| 成年女人毛片免费观看观看9 | 国产精品国产三级国产专区5o| 国产一区二区三区综合在线观看| 可以免费在线观看a视频的电影网站 | 中文字幕制服av| 精品免费久久久久久久清纯 | 亚洲图色成人| 日韩av不卡免费在线播放| 日日摸夜夜添夜夜爱| 日韩精品免费视频一区二区三区| 这个男人来自地球电影免费观看 | 免费在线观看完整版高清| 午夜老司机福利片| 国产老妇伦熟女老妇高清| 亚洲中文av在线| 国产男女内射视频| 啦啦啦啦在线视频资源| 最近最新中文字幕大全免费视频 | 少妇的丰满在线观看| 在线观看www视频免费| 欧美日韩综合久久久久久| 黑人猛操日本美女一级片| 亚洲图色成人| 色精品久久人妻99蜜桃| 黄片播放在线免费| 亚洲欧美色中文字幕在线| 一区在线观看完整版| 又黄又粗又硬又大视频| 高清视频免费观看一区二区| 色吧在线观看| 久久久久久免费高清国产稀缺| 最近中文字幕2019免费版| 午夜免费鲁丝| 男人添女人高潮全过程视频| 制服诱惑二区| 免费日韩欧美在线观看| 午夜福利免费观看在线| 一级毛片电影观看| av线在线观看网站| 亚洲色图 男人天堂 中文字幕| av不卡在线播放| 久久久久精品人妻al黑| 国产视频首页在线观看| av在线app专区| 亚洲精品,欧美精品| 午夜激情av网站| 国产成人精品在线电影| 激情五月婷婷亚洲| 巨乳人妻的诱惑在线观看| 别揉我奶头~嗯~啊~动态视频 | 美女午夜性视频免费| 久久久久精品久久久久真实原创| 国产精品久久久久久久久免| 亚洲天堂av无毛| 在线亚洲精品国产二区图片欧美| 国产国语露脸激情在线看| 欧美 日韩 精品 国产| 免费人妻精品一区二区三区视频| 中文字幕精品免费在线观看视频| 亚洲av日韩精品久久久久久密 | 午夜福利免费观看在线| 日韩成人av中文字幕在线观看| 精品视频人人做人人爽| 日日撸夜夜添| 国产爽快片一区二区三区| 亚洲精品日韩在线中文字幕| 日韩免费高清中文字幕av| 日韩熟女老妇一区二区性免费视频| 欧美另类一区| 91成人精品电影| 菩萨蛮人人尽说江南好唐韦庄| 国产乱来视频区| 高清黄色对白视频在线免费看| 亚洲欧美一区二区三区久久| 深夜精品福利| 国产成人啪精品午夜网站| 国产一区有黄有色的免费视频| 一区在线观看完整版| 国产黄色视频一区二区在线观看| 亚洲一码二码三码区别大吗| 少妇猛男粗大的猛烈进出视频| 亚洲,欧美精品.| 国产精品一区二区在线不卡| 在线观看人妻少妇| 久久这里只有精品19| 999精品在线视频| 老鸭窝网址在线观看| 美女国产高潮福利片在线看| 国产精品av久久久久免费| 黄色怎么调成土黄色| 99re6热这里在线精品视频| 伦理电影免费视频| 国产xxxxx性猛交| 各种免费的搞黄视频| 日韩制服丝袜自拍偷拍| 街头女战士在线观看网站| 免费看av在线观看网站| 男女边摸边吃奶| 国产片特级美女逼逼视频| 国产福利在线免费观看视频| 国产免费一区二区三区四区乱码| 国产一区二区三区综合在线观看| 日本av手机在线免费观看| 国产av一区二区精品久久| 亚洲国产欧美在线一区| 巨乳人妻的诱惑在线观看| 精品久久久久久电影网| 国产乱人偷精品视频| 日韩伦理黄色片| 亚洲av综合色区一区| 亚洲一卡2卡3卡4卡5卡精品中文| 韩国av在线不卡| 电影成人av| 免费黄色在线免费观看| 亚洲一码二码三码区别大吗| 一边摸一边抽搐一进一出视频| 免费观看av网站的网址| av国产久精品久网站免费入址| 美女脱内裤让男人舔精品视频| 黄色毛片三级朝国网站| 亚洲精品美女久久久久99蜜臀 | 一本色道久久久久久精品综合| 无遮挡黄片免费观看| 日韩制服骚丝袜av| 999久久久国产精品视频| 少妇人妻 视频| 婷婷成人精品国产| 国产精品成人在线| 国产精品国产三级国产专区5o| 天天躁夜夜躁狠狠久久av| 久久人人爽人人片av| 亚洲av欧美aⅴ国产| 五月天丁香电影| 1024视频免费在线观看| av女优亚洲男人天堂| 纵有疾风起免费观看全集完整版| 曰老女人黄片| 男女下面插进去视频免费观看| 一二三四在线观看免费中文在|